Pharsight Partners
IMMUNI T, Inc.
In August 2010, Pharsight formed a partnership with IMMUNI T to offer combined expertise to pharmaceutical and biotechnology industry sponsors. Operating as a Contract Research Organization (CRO) since 2006, IMMUNI T provides high quality services in immunology with emphasis on the immunogenicity of biotherapeutics, immuno-diagnostic, cell-based research and personalized medicine. IMMUNI T offers a full range of immunological services to complement the drug development process from discovery to post-marketing. More information about IMMUNI T is available at www.immunit.com.
InforSense, Ltd.
In October 2008, Pharsight announced a strategic partnership with InforSense, Ltd., the leading provider of next-generation business and scientific intelligence tools. InforSense will provide distribution services for Pharsight’s market-leading PK/PD analysis, reporting and data management software products within the Chinese pharmaceutical and biotech research and development market. Pharsight and InforSense also initiated a strategic partnership to deliver translational research solutions to the pharmaceutical industry. The strategic partnership includes opportunities for product-based collaborations to utilize biomarkers in clinical PK/PD modeling.
InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts. For more information visit www.inforsense.com.
LabLogic Systems Limited
In September 2006, Pharsight announced a
cooperation agreement with LabLogic Systems Limited to enhance the link between Debra™, LabLogic's drug metabolism Laboratory Information Management System, and Pharsight's WinNonlin® software for pharmacokinetic, pharmacodynamic and non-compartmental analysis. Under the terms of the cooperation agreement,
WinNonlin's Automation Application Programming Interface (API) is available in Debra 5.6.3, enabling users of both systems to select time-concentration data in Debra and export it to WinNonlin for analysis.
LabLogic Systems Limited started trading in 1979, initially supplying Radio HPLC, Radio TLC and Radio GC measurement instrumentation throughout the research and development industry. The company then became involved in the supply and integration of applications software to compliment its growing instrument product range. From this background, LabLogic proceeded to provide bespoke LIMS for ADME drug metabolism laboratories and has progressed to providing flexible 'off the shelf' solutions, which has resulted in LabLogic now being viewed as the world leading supplier of Laboratory Information Management Systems. More information about LabLogic is available at www.lablogic.com.